中华皮肤科杂志 ›› 2019, Vol. 52 ›› Issue (2): 77-80.doi: 10.3760/cma.j.issn.0412-4030.2019.02.001

• 专论 •    下一篇

皮肤科生物制剂的主要不良反应及对策

王刚   

  1. 第四军医大学西京皮肤医院,西安 710032
  • 收稿日期:2018-11-26 修回日期:2019-01-04 出版日期:2019-02-15 发布日期:2019-01-29
  • 通讯作者: 王刚 E-mail:xjwgang@fmmu.edu.cn

Main adverse reactions in biological agents in dermatology and their strategies

WANG Gang   

  1. Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi′an 710032, China
  • Received:2018-11-26 Revised:2019-01-04 Online:2019-02-15 Published:2019-01-29
  • Contact: WANG Gang E-mail:xjwgang@fmmu.edu.cn

摘要: 【摘要】 生物治疗是临床治疗学的重要进展,在解决重症或难治性疾病的同时,也带来一系列新的安全性问题。皮肤科生物治疗主要用于银屑病、特应性皮炎、慢性荨麻疹、恶性黑素瘤等,所用的制剂各不相同,可能诱发的不良反应也有所差异,其中最常见的是感染、过敏和自身免疫反应。进行生物治疗时要从治疗靶点、作用机制、制剂特点、患者情况等多个方面进行全方位的把控,用药前严格筛查,治疗过程中严密监视,从而最大限度地保障患者的安全。

关键词: 药物疗法, 药物毒性, 银屑病, 皮炎, 特应性, 荨麻疹, 黑色素瘤, 生物治疗, 不良反应

Abstract: 【Abstract】 Biologic therapy is a major advancement in clinical therapeutics. It provides a solution to severe and refractory diseases, meanwhile brings a series of new safety concerns. In dermatology biologic agents are mainly applied to the treatment of psoriasis, atopic dermatitis, chronic urticaria, and malignant melanoma, etc. Different biologics may induce different adverse reactions, among which the commonest are infection, allergy and autoimmune response. Administration of biologics should be strictly managed in terms of therapeutic target, mechanism of action, features of preparation, and conditions of patients. Patients should be strictly evaluated for their eligibility before treatment and closely monitored during the therapy, so as to ensure their safety.

Key words: Drug therapy, Drug toxicity, Psoriasis, Dermatitis, atopic, Urticaria, Melanoma, Biologic therapy, Adverse effect